Morphic adds second integrin partnership with Janssen deal

Morphic Therapeutic (Waltham, Mass.) and Janssen Biotech Inc. partnered to discover and develop oral integrin therapies for undisclosed diseases not adequately addressed by current therapies. The multi-target collaboration will explore

Read the full 307 word article

User Sign In